PeptideDB

(R)-Phenylpiracetam

CAS: 949925-07-9 F: C12H14N2O2 W: 218.25

(R)-Phenylpiracetam (MRZ 9547) is a dopamine transporter (DAT) inhibitor (Ki: 14.8 μM; IC50: 65.5 μM). (R)-Phenylpirac
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity (R)-Phenylpiracetam (MRZ 9547) is a dopamine transporter (DAT) inhibitor (Ki: 14.8 μM; IC50: 65.5 μM). (R)-Phenylpiracetam can be used for the research of the neurological or neuropsychiatric disorders[1][2].
Target Ki: 14.8 μM (DAT); IC50: 65.5 μM (DAT)
Invitro (R)-Phenylpiracetam displaces the binding of [125I] RTI-55 (IC50 = 4.82 μM) to human recombinant DAT expressed in CHO-K1 cells[2].
In Vivo (R)-Phenylpiracetam (50 mg/kg; p.o. or i.p.; single-dose) reaches the mouse brain tissue 15 min after administration[1].(R)-Phenylpiracetam (10, 25, 50 mg/kg; p.o.; pretreatment for 7 days) dose-dependently reduces paw oedema and the antinociceptive response on carrageenan induced mouse[1].
Name (R)-Phenylpiracetam
CAS 949925-07-9
Formula C12H14N2O2
Molar Mass 218.25
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Zvejniece L, et al. Neuroprotective and anti-inflammatory activity of DAT inhibitor R-phenylpiracetam in experimental models of inflammation in male mice. Inflammopharmacology. 2020;28(5):1283-1292. [2]. Sommer S, et al. The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats. Int J Neuropsychopharmacol. 2014;17(12):2045-2056.